Cell-based Assays Market (By Type: Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Other; By Products & Services: Reagents, Assay Kits, Microplates, Probes & Labels, Instruments & Software, Cell Lines; By Application: Basic Research, Drug Discovery, Other; By Technology: Automated Handling, Flow Cytometry, Label-free Detection, High-throughput Screening, Others; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cell-based Assays Market
5.1. COVID-19 Landscape: Cell-based Assays Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cell-based Assays Market, By Type
8.1. Cell-based Assays Market, by Type, 2024-2033
8.1.1. Cell Viability Assay
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Cytotoxicity Assay
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Cell Death Assay
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Cell Proliferation Assay
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Cell-based Assays Market, By Products & Services
9.1. Cell-based Assays Market, by Products & Services, 2024-2033
9.1.1. Reagents
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Assay Kits
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Microplates
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Probes & Labels
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Instruments & Software
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Cell Lines
9.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Cell-based Assays Market, By Application
10.1. Cell-based Assays Market, by Application, 2024-2033
10.1.1. Basic Research
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Drug Discovery
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Other Applications
10.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Cell-based Assays Market, By Technology
11.1. Cell-based Assays Market, by Technology, 2024-2033
11.1.1. Automated Handling
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Flow Cytometry
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Label-free Detection
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. High-throughput Screening
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Cell-based Assays Market, By End-use
12.1. Cell-based Assays Market, by End-use, 2024-2033
12.1.1. Pharmaceutical and Biotechnology Companies
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. Academic & Government Institutes
12.1.2.1. Market Revenue and Forecast (2021-2033)
12.1.3. Contract Research Organizations
12.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 13. Global Cell-based Assays Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2021-2033)
13.1.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.1.3. Market Revenue and Forecast, by Application (2021-2033)
13.1.4. Market Revenue and Forecast, by Technology (2021-2033)
13.1.5. Market Revenue and Forecast, by End-use (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2021-2033)
13.1.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.1.6.3. Market Revenue and Forecast, by Application (2021-2033)
13.1.6.4. Market Revenue and Forecast, by Technology (2021-2033)
13.1.6.5. Market Revenue and Forecast, by End-use (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Type (2021-2033)
13.1.7.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.1.7.3. Market Revenue and Forecast, by Application (2021-2033)
13.1.7.4. Market Revenue and Forecast, by Technology (2021-2033)
13.1.7.5. Market Revenue and Forecast, by End-use (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2021-2033)
13.2.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.2.3. Market Revenue and Forecast, by Application (2021-2033)
13.2.4. Market Revenue and Forecast, by Technology (2021-2033)
13.2.5. Market Revenue and Forecast, by End-use (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2021-2033)
13.2.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.2.6.3. Market Revenue and Forecast, by Application (2021-2033)
13.2.7. Market Revenue and Forecast, by Technology (2021-2033)
13.2.8. Market Revenue and Forecast, by End-use (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2021-2033)
13.2.9.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.2.9.3. Market Revenue and Forecast, by Application (2021-2033)
13.2.10. Market Revenue and Forecast, by Technology (2021-2033)
13.2.11. Market Revenue and Forecast, by End-use (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2021-2033)
13.2.12.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.2.12.3. Market Revenue and Forecast, by Application (2021-2033)
13.2.12.4. Market Revenue and Forecast, by Technology (2021-2033)
13.2.13. Market Revenue and Forecast, by End-use (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2021-2033)
13.2.14.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.2.14.3. Market Revenue and Forecast, by Application (2021-2033)
13.2.14.4. Market Revenue and Forecast, by Technology (2021-2033)
13.2.15. Market Revenue and Forecast, by End-use (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2021-2033)
13.3.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.3.3. Market Revenue and Forecast, by Application (2021-2033)
13.3.4. Market Revenue and Forecast, by Technology (2021-2033)
13.3.5. Market Revenue and Forecast, by End-use (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2021-2033)
13.3.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.3.6.3. Market Revenue and Forecast, by Application (2021-2033)
13.3.6.4. Market Revenue and Forecast, by Technology (2021-2033)
13.3.7. Market Revenue and Forecast, by End-use (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2021-2033)
13.3.8.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.3.8.3. Market Revenue and Forecast, by Application (2021-2033)
13.3.8.4. Market Revenue and Forecast, by Technology (2021-2033)
13.3.9. Market Revenue and Forecast, by End-use (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2021-2033)
13.3.10.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.3.10.3. Market Revenue and Forecast, by Application (2021-2033)
13.3.10.4. Market Revenue and Forecast, by Technology (2021-2033)
13.3.10.5. Market Revenue and Forecast, by End-use (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2021-2033)
13.3.11.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.3.11.3. Market Revenue and Forecast, by Application (2021-2033)
13.3.11.4. Market Revenue and Forecast, by Technology (2021-2033)
13.3.11.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2021-2033)
13.4.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.4.3. Market Revenue and Forecast, by Application (2021-2033)
13.4.4. Market Revenue and Forecast, by Technology (2021-2033)
13.4.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2021-2033)
13.4.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.4.6.3. Market Revenue and Forecast, by Application (2021-2033)
13.4.6.4. Market Revenue and Forecast, by Technology (2021-2033)
13.4.7. Market Revenue and Forecast, by End-use (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2021-2033)
13.4.8.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.4.8.3. Market Revenue and Forecast, by Application (2021-2033)
13.4.8.4. Market Revenue and Forecast, by Technology (2021-2033)
13.4.9. Market Revenue and Forecast, by End-use (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2021-2033)
13.4.10.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.4.10.3. Market Revenue and Forecast, by Application (2021-2033)
13.4.10.4. Market Revenue and Forecast, by Technology (2021-2033)
13.4.10.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2021-2033)
13.4.11.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.4.11.3. Market Revenue and Forecast, by Application (2021-2033)
13.4.11.4. Market Revenue and Forecast, by Technology (2021-2033)
13.4.11.5. Market Revenue and Forecast, by End-use (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2021-2033)
13.5.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.5.3. Market Revenue and Forecast, by Application (2021-2033)
13.5.4. Market Revenue and Forecast, by Technology (2021-2033)
13.5.5. Market Revenue and Forecast, by End-use (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2021-2033)
13.5.6.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.5.6.3. Market Revenue and Forecast, by Application (2021-2033)
13.5.6.4. Market Revenue and Forecast, by Technology (2021-2033)
13.5.7. Market Revenue and Forecast, by End-use (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2021-2033)
13.5.8.2. Market Revenue and Forecast, by Products & Services (2021-2033)
13.5.8.3. Market Revenue and Forecast, by Application (2021-2033)
13.5.8.4. Market Revenue and Forecast, by Technology (2021-2033)
13.5.8.5. Market Revenue and Forecast, by End-use (2021-2033)
Chapter 14. Company Profiles
14.1. Danaher Corporation
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Lonza Group AG
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Promega Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. F. Hoffmann-La Roche AG
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Charles River Laboratories International, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Menarini Silicon Biosystems, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Becton, Dickinson and Company
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Bio-Rad Laboratories, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Macrogen Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. DiscoverX Corporation
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client